课题基金 / 基金详情

Elucidation of mechanisms for neuronal death caused by mutant genes in amyotrophic lateral sclerosis

Elucidation of mechanisms for neuronal death caused by mutant genes in amyotrophic lateral sclerosis
阐明肌萎缩侧索硬化症突变基因引起的神经元死亡机制
批准号:
15590908
负责人:
NIIKURA Takako
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NIIKURA Takako的其他基金

相似基金

相关文献

中文摘要
翻译
肌萎缩侧索硬化症(ALS)是一种以运动神经元特异性变性为特征的进行性致死性神经退行性疾病。大约20%的家族性肌萎缩侧索硬化症(FALS)病例与超氧化物歧化酶1(SOD1)的特定突变有关。SOD1突变体被认为通过“获得毒性功能”而导致运动神经元死亡。另一方面,由另一个与FALS相关的基因als2编码的alsin被认为是通过功能丧失而导致ALS的,因为als2中与faS相关的突变是隐性遗传的。基于alsin有助于神经保护的假设,我们检验了野生型alsin是否能保护细胞免受SOD1突变体诱导的毒性。我们发现在运动神经元细胞系中,alsin与Fals连锁的SOD1突变体共表达可显著抑制SOD1突变体诱导的细胞死亡。此外,野生型alsin与FALS连锁的SOD1突变体结合,但不与野生型SOD1结合,这表明alsin的神经保护作用与与SOD1突变体形成复合体有关。我们还发现,九个残基的多肽ADNF在体外可以抑制FALS连锁SOD1突变体引起的运动神经元死亡,并改善FALS转基因小鼠的运动能力。
英文摘要
Amyotrophic lateral sclerosis(ALS) is a progressive fatal neurodegenerative disease that is characterized with specific degeneration of motor neurons. Specific mutations in superoxide dismutase 1(SOD1) are associated with approximately 20% of familial ALS(FALS) cases. SOD1 mutants are considered to cause motoneuronal death by ‘gain of toxic function'. On the other hand, alsin encoded by another FALS-responsible gene, ALS2, is considered to cause ALS by ‘loss of function', because FALS-linked mutations in ALS2 are recessively inherited. Based on the hypothesis that alsin contributes neuroprotection, we examined whether wild-type alsin protect cells from SOD1 mutants-induced toxicity. We found that co-expression of alsin with FALS-linked SOD1 mutant drastically suppressed SOD1 mutants-induced cell death in motoneuronal cell line. Further, the wild-type alsin binds to FALS- linked SOD1 mutants, but not to wild-type SOD1, suggesting that neuroproptection of alsin correlates with complex formation with SOD1 mutants.We also found that ADNF, a nine-residue polypeptide, suppressed motoneuronal death caused by FALS-linked SOD1 mutants in vitro and improved motor performance of G93A-SOD1 transgenic mice, a model of FALS.
期刊论文(57)
专著(0)
科研奖励(0)
会议论文
A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice
护脑素衍生物 S14G-HN 可预防β淀粉样蛋白诱导的小鼠记忆障碍
DOI: --
发表时间: 2005
期刊: J Neurosci Res. 79(5)
影响因子: --
作者: [Tajima H., Kawasumi M., Shiba T., Yamada M., Yamashita K., Nawa M., Kita Y., Kouyama K., Aiso S., Matsuoka M., Niikura T.]
通讯作者: Niikura T.
Humanin: after the discovery
护脑素:发现之后
DOI: --
发表时间: 2004
期刊: Mol Neurobiol. 30(3)
影响因子: --
作者: [Niikura T., Chiba T., Aiso S., Matsuoka M., Nishimoto I.]
通讯作者: Nishimoto I.
Abe Y., et al.: "Analysis of neurons created from wild-type and Alzheimer's mutation knock-in embryonic stem cells by a highly efficient differentiation protocol"Journal of Neuroscience. 23. 8513-8525 (2003)
Abe Y. 等人:“通过高效分化方案分析由野生型和阿尔茨海默病突变敲入胚胎干细胞产生的神经元”《神经科学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
The amino- and carboxyl-terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms : study of 27 different presenilin 1 mutants.
早老素 1 的氨基和羧基末端突变体通过不同的毒性机制导致神经元细胞死亡:对 27 种不同早老素 1 突变体的研究。
DOI: --
发表时间: 2004
期刊: J.Neurosci.Res. 75
影响因子: --
作者: [Hashimoto Y., et al.]
通讯作者: et al.
29
    The role of a cytoprotective peptide factor against Alzheimer's disease pathologies in anti-brain aging
    • 批准号:
      18K05342
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2018
    • 负责人:
      NIIKURA Takako
    • 依托单位:
    Molecular mechanisms of amyloid beta metabolism by a cell survival factor
    • 批准号:
      24890236
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.91万
    • 财政年份:
      2012
    • 负责人:
      NIIKURA Takako
    • 依托单位:
    Functional analysis of neuroprotective factor Humanin as a basis for Alzheimer's disease therapy
    • 批准号:
      17590894
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      NIIKURA Takako
    • 依托单位:
    海外基金